AIM

AIM ImmunoTech

22 hedge funds and large institutions have $4.64M invested in AIM ImmunoTech in 2020 Q2 according to their latest regulatory filings, with 12 funds opening new positions, 4 increasing their positions, 2 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
22
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change

Top Sellers

1 -$498K
2 -$327K
3 -$72K
4
Osaic Holdings
Osaic Holdings
Arizona
-$46.6K
5
Goldman Sachs
Goldman Sachs
New York
-$38K
Name Holding Trade Value Shares
Change
Change in
Stake
1
$1.18M
2
$1.18M
3
$915K
4
$383K
5
$165K
6
$143K
7
$115K
8
$91K
9
$75K
10
$72K
11
$63K
12
$51K
13
$44K
14
$39K
15
$35K
16
$32K
17
$29K
18
$29K
19
$1K
20
$565
21
22
23
24
25